Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulphate for Sucking Reflex in Severe Birth Asphyxia
NCT06468475Completed
- Sponsor
- RESnTEC (Research and Technology) Ltd
- Start
- Oct 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of magnesium sulfate in birth asphyxia, sponsored by RESnTEC (Research and Technology) Ltd. Primary endpoint: Neonatal Sucking Reflex Efficacy at 72 hours. Started Oct 2023; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
birth asphyxia
Beyond the preview
Go deeper on NCT06468475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06468475.